Buscar resultados de ensayos clínicos

Patrocinado por

Mucopolysaccharidosis IV - 18 Studies Found

Estado Estudiar
Completed Nombre del estudio: A Double-Blind Study to Evaluate the Efficacy and Safety of BMN 110 in Patients With Mucopolysaccharidosis IVA (Morquio A Syndrome)
Condición: MPS IV A
Fecha: 2011-01-10
Intervenciones:
  • Drug: BMN 110 Weekly BMN 110 W
Approved for marketing Nombre del estudio: BMN 110 US Expanded Access Program
Condición:
  • Mucopolysaccharidosis IVA
  • Morquio A Syndrome
  • MPS IVA

    • Fecha: 2013-05-15
    Intervenciones: Drug: BMN 110
Terminated Nombre del estudio: A Study to Evaluate the Long-Term Efficacy and Safety of BMN 110 in Patients With Mucopolysaccharidosis IVA (Morquio A Syndrome)
Condición:
  • MPS IV A
  • Mucopolysaccharidosis IVA
  • Morquio A Syndrome

    • Fecha: 2010-10-28
    Intervenciones: Drug: BMN 110 Patients will receive an intravenous infusion of BMN110 at 2.0mg/kg/week, over a period of
Completed Nombre del estudio: A Study to Evaluate the Safety, Tolerability and Efficacy of BMN 110 in Subjects With Mucopolysaccharidosis IVA
Condición: MPS IV A
Fecha: 2009-04-10
Intervenciones: Drug: BMN 110 Subjects will receive a weekly 4- to 5-hour
Enrolling by invitation Nombre del estudio: BMN 110 Phase 3B in Australian Patients
Condición: Mucopolysaccharidosis IVA (Morquio A Syndrome)
Fecha: 2013-09-10
Intervenciones: Drug: BMN 110 All pateints receive treatment with BMN 110
Terminated Nombre del estudio: Efficacy and Safety Study of BMN 110 for Morquio A Syndrome Patients Who Have Limited Ambulation
Condición:
  • Mucopolysaccharidosis IVA
  • Morquio A Syndrome
  • MPS IVA

    • Fecha: 2012-09-17
    Intervenciones: Drug: BMN 110 Drug will be delivered through a 4 hour (approximate) IV infusion at a dosage amount of 2.
Terminated Nombre del estudio: Safety and Exercise Study of Two Doses of BMN 110 for Morquio A Syndrome
Condición:
  • Mucopolysaccharidosis IVA
  • Morquio A Syndrome
  • MPS IVA

    • Fecha: 2012-05-24
    Intervenciones:
    • Drug: BMN 110 Weekly IV infusi
Completed Nombre del estudio: Study of BMN 110 in Pediatric Patients < 5 Years of Age With Mucopolysaccharidosis IVA (Morquio A Syndrome)
Condición:
  • Mucopolysaccharidosis IVA
  • Morquio A Syndrome
  • MPS IVA

    • Fecha: 2011-12-22
    Intervenciones: Drug: BMN 110 Patients will receive intravenous (IV) infusions of study drug at a dose of 2.0 mg/kg/wk o
<<< Previous